Global Healthcare Contract Research Outsourcing Market size is expected to be worth around US$ 100.9 billion by 2033 from US$ 50.8 billion in 2023 ...

Visits to the doctor could be improved with the use of AI to record a patient's medical history provided concerns about ...

Arquitos returned 29.6% net of fees and expenses in 2024, compared to 25.0% for the S&P 500. Click here to read the full ...

Compelling opportunity expected to unlock substantial value through enhanced focus, tailored investment and capital allocation, and optimized market valuation "New BD," built on momentum of BD 2025 ...

Governor Maura Healey signed House Bill 5159 into law, toughening the rules and increasing the risks for private equity ...

Good morning, and welcome to the Bio-Techne Earnings Conference Call for the Second Quarter of Fiscal Year 2025. At this time, all participants have been placed in a listen-only mode and the call will ...

SG Americas Securities LLC lowered its position in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 44.8% during the fourth quarter, HoldingsChannel reports. The firm owned 49,343 shares ...

Q4 2024 Earnings Call Transcript February 4, 2025 Operator: Hello, and welcome to Regeneron Pharmaceuticals Fourth Quarter ...

Q4 2024 Earnings Call Transcript February 4, 2025 Merck & Co., Inc. misses on earnings expectations. Reported EPS is $1.72 ...

SG Americas Securities LLC cut its position in Biohaven Ltd. (NYSE:BHVN – Free Report) by 45.5% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 9,001 shares ...

Percheron Therapeutics says it will abandon its lead drug candidate altogether, following December's Duchenne muscular dystrophy trial flop.

Raul Fernandez; President, Chief Executive Officer, Director; DXC Technology Co Robert Del Bene; Chief Financial Officer, Executive Vice President; DXC Technology Co Ladies and gentlemen, thank you ...